|
|
https://mb.cision.com/Public/18595/logo/86a99b25f755738d_org.jpg
BIMZELX^=C2=AE=E2=96=BC bimekizumab Receives First Positive Health Tec=
hnology Assessment Worldwide
=C2=B7 The UK=E2=80=99s National Institute for Health and Care Excellence p=
ublished its final Technology Appraisal Guidance recommending bimekizumab a=
s a treatment option for adults with severe plaque... See more |
|
|
|
| |
|
| |
|
|
https://mb.cision.com/Public/18595/logo/86a99b25f755738d_org.jpg
Transparency notification Wellington
=C2=B7 Notification referring to situation on 1 September 2021
=C2=B7 Threshold crossed: 7.5%
=C2=B7 Latest holding: 7.46%=C2=A0
Brussels Belgium, 3 September 2021 =E2=80=93 20:05 CEST =E2=80=93 regul=
ated information
1.=C2=A0=C2=A0Summary of the notification
Pursuant to... See more |
|
|
|
| |
|
| |
|
|
https://mb.cision.com/Public/18595/logo/86a99b25f755738d_org.jpg
Disposals of own shares
Brussels Belgium, 3 September 2021 =E2=80=93 20:00 CEST =E2=80=93 regul=
ated information
Disposal of own shares
In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB announces that, following exercises o=
f stock options by... See more |
|
|
|
| |
|
| |
|
|
PRESS RELEASE
Regulated information – Inside information
Brussels, 31 August 2021 – 18:00 CET
Disclosure of a transparency notification
Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major holdings
Participation notification by CANDRIAM
In accordance with the... See more |
|
|
|
| |
|
| |
|
|
p Information réglementée le 30 août 2021/p
pPublication effectuée en application de l'article 15, §1super/sup de la loi du 2 mai 2007 la "strongLoi/strong" relative à la publicité des participations importantes dans des émetteurs dont les actions sont admises à la négociation sur un marché... | |
Search :
